Tinea Management in the Indian Setting
On this page
Direct answer
India's recalcitrant tinea epidemic is driven largely by over-the-counter topical steroid–antifungal combination creams, which convert a curable dermatophyte infection into extensive, relapsing, steroid-modified disease while simultaneously selecting drug resistance. Correct management means stopping the combination cream, confirming with potassium hydroxide microscopy, and treating with a plain topical azole or allylamine for body tinea, or systemic terbinafine or itraconazole for extensive disease — with awareness, per current Indian guidance, that Trichophyton terbinafine resistance has made itraconazole the common fallback. This NEET-PG Medicine topic rewards knowing both the drugs and the uniquely Indian prescribing trap.
What you must remember
- Never prescribe or continue clobetasol-plus-antifungal combination creams: they cause tinea incognito, spread, atrophy and treatment failure.
- Confirm with 10–20% KOH microscopy of skin scrapings taken from the active edge before systemic therapy.
- Body tinea (tinea corporis/cruris): topical luliconazole 1%, sertaconazole, eberconazole, amorolfine or clotrimazole for 2–4 weeks.
- Extensive, steroid-modified or recurrent disease: oral terbinafine 250 mg daily for 2–6 weeks, or itraconazole 200 mg daily — the common fallback given emerging terbinafine resistance in Indian Trichophyton strains.
- Tinea capitis in children requires systemic therapy: griseofulvin (favoured for Microsporum) or terbinafine (favoured for Trichophyton), with microneutralised fat-rich food for griseofulvin absorption, typically 6–8 weeks.
- Onychomycosis: terbinafine 6 weeks for fingernails, 12 weeks for toenails.
- Kerion (inflammatory tinea capitis) still needs systemic antifungals; adding oral steroids is adjunctive in severe inflammation, and bacterial superinfection is treated on merit.
- Household and clothing hygiene matters: iron clothes worn over affected areas, keep skin folds dry, treat affected family members simultaneously.
- Insulin resistance, occlusion, sweating and sharing of towels drive the groin and body epidemics seen in Indian outpatient departments.
How to work through a typical case
A 24-year-old man presents with intensely itchy, rapidly spreading plaques over the groin, buttocks and trunk for four months. He has used a "four-drug" cream containing clobetasol, ofloxacin, ornidazole and an antifungal, purchased over the counter, with initial improvement and relentless rebound. Examination shows large, polycyclic, poorly demarcated plaques with minimal scale and scattered pustules — the morphology of steroid-modified tinea.
Step one: stop the combination cream and explain why — the steroid suppresses inflammation, masks the ring, thins skin and promotes spread; this single instruction does more than any prescription. Step two: scrape the active edge for KOH; septate hyphae confirm dermatophytosis and justify systemic therapy given the extent. Step three: treat systemically — oral terbinafine 250 mg daily for four weeks is the traditional choice, but in the current Indian scenario of terbinafine-resistant Trichophyton, itraconazole 200 mg daily for a similar duration is the frequent alternative; counsel on itraconazole's acid-environment absorption (take with food or cola) and drug interactions. Step four: add a plain topical agent to affected folds, keep the area dry, and advise hot-ironing clothes and treating infected contacts. Step five: warn about post-inflammatory pigmentation, set a realistic endpoint — scale and itch resolve before discolouration fades — and schedule review at two to four weeks rather than allowing self-directed repetition of the culprit cream.
Where students slip
The commonest slip is praising combination creams for rapid relief: the viva expects the paradox that the fastest-relieving cream causes the worst disease. Second, candidates treat extensive groin disease topically for weeks — beyond a modest surface area, topical therapy fails and systemic treatment is proper. Third, tinea capitis mismanaged topically is a classic error: no topical agent eradicates scalp infection, and kerion is managed with systemic antifungals rather than antibiotics or incision. Fourth, forgetting the KOH before oral therapy wastes the diagnostic moment, since steroid-modified lesions can mimic eczema, psoriasis or even cutaneous lupus. Finally, examiners now ask directly about terbinafine resistance in Indian strains — answering as if 2010 protocols apply marks the answer as dated.
Frequently asked questions
Why are steroid–antifungal combination creams harmful in tinea?
The potent steroid suppresses local immunity and inflammation, producing tinea incognito with spread, atrophy and poor clearance, while partial antifungal exposure encourages resistance.
What is first-line systemic therapy for extensive tinea corporis?
Oral terbinafine 250 mg daily classically; itraconazole 200 mg daily is the standard alternative where terbinafine resistance is suspected or treatment fails.
How is tinea capitis treated?
Systemically — griseofulvin or terbinafine for 6–8 weeks chosen by organism where known (griseofulvin for Microsporum, terbinafine for Trichophyton); topical therapy alone is inadequate.
What is tinea incognito?
Steroid-modified tinea: altered morphology with loss of the raised active edge and scale, pustules, expansion and relapse on withdrawal of the cream.
Which practical hygiene measures accompany drug therapy?
Ironing clothes worn over infected sites, drying skin folds thoroughly, not sharing towels or clothing, and simultaneous treatment of affected household members to break reinfection cycles.